Benzinga | Aug 10, 2021 07:28AM EDT

Finch Therapeutics Group Q2 EPS $(0.32) Up From $(1.02) YoY, Sales $2.83M Up From $2.35M YoY

Finch Therapeutics Group (NASDAQ:FNCH) reported quarterly losses of $(0.32) per share. This is a 68.63 percent increase over losses of $(1.02) per share from the same period last year. The company reported $2.83 million in sales this quarter. This is a 20.48 percent increase over sales of $2.35 million the same period last year.